Currently out of the existing stock ratings of Eddie Hickman, 29 are a BUY (96.67%), 1 are a HOLD (3.33%).

Eddie Hickman

Work Performance Price Targets & Ratings Chart

Analyst Eddie Hickman, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 45.83% that have a potential upside of 69.14% achieved within 166 days.

Eddie Hickman’s has documented 50 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GHRS, GH Research PLC at 07-Aug-2026.

Wall Street Analyst Eddie Hickman

Analyst best performing recommendations are on ISEE (IVERIC BIO).
The best stock recommendation documented was for ISEE (IVERIC BIO) at 9/7/2022. The price target of $35 was fulfilled within 236 days with a profit of $20.06 (134.27%) receiving and performance score of 5.69.

Average potential price target upside

ISEE IVERIC bio TARS Tarsus Pharmaceuticals OTLK OUTLOOK THERAPEUTICS INC GHRS GH Research PLC CYBN Cybin ATAI ATAI Life Sciences BV

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Jan-2020

$40

3 years 5 months 5 days ago
(08-May-2023)

4/5 (80%)

$8.4 (26.58%)

470

Buy Since 02-Aug-2022

$34

$-5.95 (-14.89%)

$26

3 years 5 months 10 days ago
(03-May-2023)

2/3 (66.67%)

$-3.21 (-8.63%)

116

Hold Since 02-May-2023

$35

$-4.95 (-12.39%)

$35

3 years 5 months 11 days ago
(02-May-2023)

5/6 (83.33%)

$-2.72 (-7.21%)

247

Buy Since 04-Aug-2021

$35

$-4.95 (-12.39%)

3 years 5 months 12 days ago
(01-May-2023)

1/2 (50%)

$-3.05 (-8.02%)

42

Buy Since 02-Mar-2022

$40

$0.05 (0.13%)

$34

3 years 5 months 12 days ago
(01-May-2023)

2/3 (66.67%)

$1.95 (5.12%)

318

Show more analysts

Please expand the browser size to see the chart

Which stock is Eddie Hickman most bullish on?

Potential upside of $18.89 has been obtained for GHRS (GH RESEARCH PLC)

Which stock is Eddie Hickman most reserved on?

Potential downside of -$0 has been obtained for ATAI (ATAI LIFE SCIENCES BV)

What Year was the first public recommendation made by Eddie Hickman?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?